PUBLICATIONS

SN	TITLE	RESEARCH AREAS	YEAR OF PUBLICATION
1	Individual and Sexual Network Predictors of HIV Incidence Among Men Who Have Sex With Men in Nigeria	HIV/AIDS	01/03/2019
2	Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria	MNCH	01/03/2019
3	TLR10 senses HIV-1 proteins and significantly enhances HIV-1 infection	HIV/AIDS	01/02/2019
4	Prevalence, Predictors, and Successful Treatment Outcomes of Xpert MTB/RIF-identifiedRifampicin-resistant Tuberculosis in Post conflict Eastern Democratic Republic of the Congo, 2012-2017: A Retrospective Province-Wide Cohort Study	TB	01/02/2019
5	Baseline PI susceptibility by HIV-1 Gag-protease phenotyping and subsequent virological suppression with PI-based second-line ART in Nigeria	HIV/AIDS	01/02/2019
6	Correlates of reported modern contraceptive use among postpartum HIV-positive women in rural Nigeria: an analysis from the MoMent prospective cohort study	MNCH	01/01/2019
7	Prevalence and incidence of genital warts and cervical Human Papillomavirus infections in Nigerian women	Cancer	01/01/2019
8	Association between HIV-1 subtype and drug resistance in Nigerian infants	HIV/AIDS	01/01/2019
9	“They do not see us as one of them”: a qualitative exploration of mentor mothers’ working relationships with healthcare workers in rural North-Central Nigeria	MNCH	01/09/2018
10	Hepatitis C virus surveillance and identification of human pegivirus 2 in a large Cameroonian cohort	Other infections	01/09/2018
11	Universal Target Capture of HIV Sequences From NGS Libraries	HIV/AIDS	01/09/2018
12	Individual and Network Factors Associated With HIV Care Continuum Outcomes Among Nigerian MSM Accessing Health Care Services	HIV/AIDS	01/09/2018
13	The role of connected diagnostics in strengthening regional, national and continental African disease surveillance	Research capacity building	01/08/2018
14	Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria	HIV/AIDS	01/08/2018
15	Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study	HIV/AIDS	01/08/2018
16	Hand hygiene practices among nurses in health facility in a semi-urban setting	Other infections	01/07/2018
17	Prevalence of anti-hepatitis C antibodies and its co-infection with HIV in rural Cameroon	Other infections	01/07/2018
18	Secular trend in interobserver agreement of VIA diagnosis for cervical cancer screening in Nigeria	Cancer	01/06/2018
19	Burden of depressive symptoms and non-alcohol substance abuse; and their association with alcohol use and partner violence: a cross-sectional study in four sub-Saharan Africa countries	NCDx	01/06/2018
20	Health facility delivery in sub-Saharan Africa: successes, challenges, and implications for the 2030 development agenda	Research capacity building	01/06/2018
21	Pediatric to adult healthcare transitioning for adolescents living with HIV in Nigeria: A national survey	MNCH	01/06/2018
22	Age, HIV status, and research context determined attrition in a longitudinal cohort in Nigeria	HIV/AIDS	01/04/2018
23	Generating evidence for health policy in challenging settings: lessons learned from four prevention of mother-to-child transmission of HIV implementation research studies in Nigeria	MNCH	01/04/2018
24	Quality of life of patients treated for prostate cancer in a Nigerian hospital	Cancer	01/03/2018
25	Achieving Viral Suppression in 90% of People Living with HIV on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities	HIV/AIDS	01/03/2018
26	HIV status disclosure to male partners among rural Nigerian women along the prevention of mother-to-child transmission of HIV cascade: a mixed methods study	MNCH	01/03/2018
27	Evaluation of Genxpert Real Time PCR POC in the Diagnosis of Multidrug Resistant TB Among Patients Attending NTBLTC Saye-Zaria Nigeria	TB	01/03/2018
28	Correction to: Adolescent Coordinated Transition (ACT) to improve health outcomes among young people living with HIV in Nigeria: study protocol for a randomized controlled trial	Clinical trial	01/02/2018
29	Consumption of processed food dietary patterns in four African populations	Other infections	01/02/2018
30	Gaps and strategies in developing health research capacity: experience from the Nigeria Implementation Science Alliance	Research capacity building	01/02/2018
31	In vitro Antimycobacterial Screening of Ficus sycomorus Extracts on Susceptible Strain of Mycobacterium tuberculosis	TB	01/02/2018
32	Data resource profile: Cardiovascular H3Africa Innovation Resource (CHAIR)	Research capacity building	01/12/2018
33	Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial	HIV/AIDS	01/01/2018
34	Integrating community pharmacy into community based anti-retroviral therapy program: A pilot implementation in Abuja, Nigeria	HIV/AIDS	01/01/2018
35	Cancers attributable to alcohol consumption in Nigeria	Cancer	01/04/2017
36	Test–Retest Reliability of Self-Reported Sexual Behavior History in Urbanized Nigerian Women	Cancer	01/04/2017
37	Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study	Cancer	01/04/2017
38	Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women	Cancer	01/04/2017
39	Integrated genomic and molecular characterization of cervical cancer	Cancer	01/04/2017
40	Randomized trial evaluating self-sampling for HPV DNA based tests for cervical cancer screening in Nigeria	CLinical trial	01/04/2017
41	Multicenter Pivotal Clinical Trial of Urine Malaria Test for Rapid Diagnosis of Plasmodiumfalciparum Malaria	Clinical trial	01/04/2017
42	Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations	HIV/AIDS	01/04/2017
43	Rectal microbiota among HIV-uninfected, untreated HIV, and treated HIV-infected in Nigeria	HIV/AIDS	01/04/2017
44	Phylodynamic analysis to inform prevention efforts in mixed HIV epidemics	HIV/AIDS	01/04/2017
45	Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with Hiv Infection in Nigeria	HIV/AIDS	01/04/2017
46	Mutational Correlates of Virological Failure in Individuals Receiving a WHO-RecommendedTenofovir-Containing First-Line Regimen: An International Collaboration	HIV/AIDS	01/04/2017
47	Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria	HIV/AIDS	01/04/2017
48	Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon	HIV/AIDS	01/04/2017
49	Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study	HIV/AIDS	01/04/2017
50	Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations	HIV/AIDS	01/04/2017
51	Modeling the Impact of Retention Interventions on Mother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi, Nigeria, and Zimbabwe	MNCH	01/04/2017
52	The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe	MNCH	01/04/2017
53	The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study	MNCH	01/04/2017
54	The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study	MNCH	01/04/2017
55	Correlates of facility delivery for rural HIV-positive pregnant women enrolled in the MoMent Nigeria prospective cohort study	MNCH	01/04/2017
56	Variation in neonatal mortality and its relation to country characteristics in sub-Saharan Africa: an ecological study	MNCH	01/04/2017
57	A Mixed-Methods Study on Acceptability, Tolerability, and Substitution of Brown Rice for White Rice to Lower Blood Glucose Levels among Nigerian Adults	NCDx	01/04/2017
58	Mycoplasma hominis and Mycoplasma genitaliumin the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection	Other infections	01/04/2017
59	Sexual partner characteristics and incident rectal Neisseria gonorrhoeae and Chlamydia trachomatis infections among gay men and other men who have sex with men (MSM): a prospective cohort in Abuja and Lagos, Nigeria	Other infections	01/04/2017
60	Status of Primary Health Workforce in a Nigerian State: Findings from Enrollment into a Digital Health Workforce Registry	Research capacity building	01/04/2017
61	Lessons Learned from Biospecimen Shipping Among the Human Heredity and Health in Africa Biorepositories	Research capacity building	01/04/2017
62	Selecting a Laboratory Information Management System for Biorepositories in Low- and Middle-Income Countries: The H3Africa Experience and Lessons Learned	Research capacity building	01/04/2017
63	Improving Data Quality in a Resource Constraint Public Health Organization in Nigeria with Divide and Conquer and Lot Quality Assurance Sampling Approach	Research capacity building	01/04/2017
64	Accessing Biospecimens from the H3Africa Consortium	Research capacity building	01/04/2017
65	Trends in prevalence of multi drug resistant tuberculosis in sub-Saharan Africa: A systematic review and meta-analysis.	TB	01/04/2017
66	Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges	TB	01/04/2017
67	Delay in the Provision of Antiretroviral Therapy to HIV-infected TB Patients in Nigeria	TB	01/04/2017
68	A Case Study of Multi Drug-Resistant Tuberculosis (MDR-TB), HIV and Diabetes Mellitus (Dm) Comorbidity: Triple Pathology; Challenges and Prospects	TB	01/04/2017
69	Cognitive Function Among Antiretroviral Treatment–Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria	HIV/AIDS	01/12/2017
70	A Socio-Ecological Examination of Treatment Access, Uptake and Adherence Issues Encountered By HIV-Positive Women in Rural North-Central Nigeria	HIV/AIDS	01/12/2017
71	ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in ClinicalSpecimens	HIV/AIDS	01/12/2017
72	Cardiovascular Risk Factors in South-Western Nigeria: A WHO StepWise Approach	Other infections	01/12/2017
73	ACCME Research Group as part of the H3Africa Consortium; Cohort Profile: African Collaborative Center for Microbiome and Genomics Research’s (ACCME) Human Papillomavirus (HPV) and Cervical Cancer Study.	Genetics and Genomics	21/12/2024
74	A Decade of Monitoring HIV Epidemics in Nigeria: Positioning for Post-2015 Agenda.	HIV/AIDS	21/12/2024
75	Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.	HIV/AIDS	21/12/2024
76	Depression, suicidality, and alcohol use disorder among people living with HIV/AIDS in Nigeria	HIV/AIDS	21/12/2024
77	Immunological and clinical assessment of adult HIV patients following switch to second-line antiretroviral regimen in a large HIV Program in North-central Nigeria.	HIV/AIDS	21/12/2024
78	Modeling the Impact of Retention Interventions onMother-to-Child Transmission of HIV: Results From INSPIRE Studies in Malawi,Nigeria, and Zimbabwe.	MNCH	21/12/2024
79	The Roles of Expert Mothers Engaged in Prevention of Mother-to-Child Transmission (PMTCT) Programs: A Commentary on the INSPIRE Studies in Malawi, Nigeria, and Zimbabwe	MNCH	21/12/2024
80	Test-Retest Reliability of Self-Reported Sexual Behavior History in Urbanized Nigerian Women.	Research capacity building	21/12/2024
81	Paucity of HPV-Related Head and Neck Cancers (HNC) in Nigeria.	Cancer	21/12/2024
82	The Burden of Human Papilloma Virus Associated Cancers in Nigeria.	Cancer	21/12/2024
83	Cancers Attributable to Infectious Agents in Nigeria: 2012-2014	Cancer	21/12/2024
84	Delays in breast cancer presentation and diagnosis in Nigeria.	Cancer	21/12/2024
85	Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis.	Cancer	21/12/2024
86	Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.	Cancer	21/12/2024
87	Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.	Cancer	21/12/2024
88	Qualitative study of barriers to cervical cancer screening among Nigerian women.	Cancer	21/12/2024
89	Psychological Stressors and Coping Strategies Used by Adolescents Living with and Not Living with HIV Infection in Nigeria.	HIV/AIDS	21/12/2024
90	Seeking wider access to HIV testing for adolescents in sub-Saharan Africa.	HIV/AIDS	21/12/2024
91	Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria.	HIV/AIDS	21/12/2024
92	Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial	HIV/AIDS	21/12/2024
93	HIV associated high-risk HPV infection among Nigerian women	HIV/AIDS	21/12/2024
94	Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.	HIV/AIDS	21/12/2024
95	Implementing Quality Assurance in HIV testing and POC in Nigeria: In-country Experience.	HIV/AIDS	21/12/2024
96	Multicenter Pivotal Clinical Trial of Urine Malaria Test for Rapid Diagnosis of Plasmodium falciparum Malaria	Malaria	21/12/2024
97	Linkage to Care, Early Infant Diagnosis, and Perinatal Transmission Among Infants Born to HIV-Infected Nigerian Mothers: Evidence From the Healthy Beginning Initiative.	MNCH	21/12/2024
98	Identifying and Prioritizing Implementation Barriers, Gaps, and Strategies Through the Nigeria Implementation Science Alliance: Getting to Zero in the Prevention of Mother-to-Child Transmission of HIV.	MNCH	21/12/2024
99	Evaluating Religious Influences on the Utilization of Maternal Health Services among Muslim and Christian Women in North-Central Nigeria	MNCH	21/12/2024
100	Building Sustainable Local Capacity for Global Health Research in West Africa.	Research capacity building	21/12/2024
101	Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women.	Cancer	21/12/2024
102	Developing National Cancer Registration in Developing Countries - Case Study of the Nigerian National System of Cancer Registries.	Cancer	21/12/2024
103	Comparability, diagnostic validity and completeness of Nigerian cancer registries.	Cancer	21/12/2024
104	Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening.	Cancer	21/12/2024
105	Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria	HIV/AIDS	21/12/2024
106	Partner HIV serostatus disclosure and determinants of serodiscordance among prevention of mother to child transmission clients in Nigeria.	HIV/AIDS	21/12/2024
107	Can oral fluid testing be used to replace blood-based HIV rapid testing to scale up access to diagnosis and treatment in Cameroon?	HIV/AIDS	21/12/2024
108	Baseline Clinical Profile of a ‘normal population’ of HIV Exposed Sero-Negative (HESN) partners may Impact HIV Biomedical Prevention Studies Negatively.	HIV/AIDS	21/12/2024
109	Uptake of Treatment as Prevention for HIV and Continuum of Care among HIV-positive Men who have Sex with Men in Nigeria	HIV/AIDS	21/12/2024
110	Adherence to anti-retroviral therapy in North Central Nigeria.	HIV/AIDS	21/12/2024
111	Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV1 RNA Viral Load in Abuja, Nigeria.	HIV/AIDS	21/12/2024
112	Current Trends in the detection of Acute HIV Infection among Blood Donors: Reliability of Pooled Nucleic Acid Amplification Technology and the Need for Population Specific Algorithms	HIV/AIDS	21/12/2024
113	Analysis of Reported Cases of Lassa Fever in Plateau State and the Need for Strategic Action Plan	Other infections	21/12/2024
114	Update on HIV-1 Acquired and Transmitted Drug Resistance in Africa	Pharmacoepid	21/12/2024
115	Doing No Harm? Adverse Events in a Nation-Wide Cohort of Patients with Multidrug-Resistant Tuberculosis in Nigeria.	Pharmacoepid	21/12/2024
116	Procurement and Supply Management System for MDR-TB in Nigeria: Are the Early Warning Targets for Drug Stock Outs and Over Stock of Drugs Being Achieved?	TB	21/12/2024
117	Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.	TB	21/12/2024
118	Debunking the myths perpetuating low implementation of isoniazid preventive therapy amongst human immunodeficiency virus-infected persons	TB	21/12/2024
119	Long-Term Outcome of Second-Line Antiretroviral Therapy in Resource-Limited Settings	HIV/AIDS	21/12/2024
120	Comprehensive reference ranges for hematology and clinical chemistry laboratory parametersderived from normal Nigerian adults	HIV/AIDS	21/12/2024
121	Comprehensive Reference Ranges for Clinical Hematology and Chemistry Laboratory Parameters Derived from Normal Nigerian adults.	HIV/AIDS	21/12/2024
122	The impact of mentor mother programs on PMTCT service uptake and retention-in-care at primary health care facilities in Nigeria: a prospective cohort study.	MNCH	21/12/2024
123	The Impact of Structured Mentor Mother Programs on 6-Month Postpartum Retention and Viral Suppression among HIV-Positive Women in Rural Nigeria: A Prospective Paired Cohort Study.	MNCH	21/12/2024
124	The Impact of Structured Mentor Mother Programs on Presentation for Early Infant Diagnosis Testing in Rural North-Central Nigeria: A Prospective Paired Cohort Study.	MNCH	21/12/2024
125	Obesity epidemic has emerged among Nigerians	NCDx	21/12/2024
126	Consensus standards for introductory e-learning courses in human participants research ethics	Reaserch capacity building	21/12/2024
127	Optimizing Mycobacterium tuberculosis detection in resource limited settings.	TB	21/12/2024
128	RPS19 and TYMS SNPs and Prevalent High Risk Human Papilloma Virus Infection in Nigerian women	Cancer	21/12/2024
129	Discordant couples cohort is still relevant for HIV vaccine studies despite low transmission rates: Canadian-Nigerian experience	HIV/AIDS	21/12/2024
130	Preparing for HIV Vaccine Trials in Nigeria: Building the Capacity of the Community and National Coordinating, Regulatory and Ethical Bodies.	HIV/AIDS	21/12/2024
131	Mycobacterial etiology of pulmonary tuberculosis and association with HIV infection and multidrub resistance in northern Nigeria.	TB	21/12/2024
132	The role of hospital-based cancer registries in low and middle income countries-The Nigerian Case Study.	Cancer	21/12/2024
133	Cancer incidence in Nigeria: a report from population-based cancer registries. Cancer	Cancer	21/12/2024
134	Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in Nigeria.	Cancer	21/12/2024
135	Digital cervicography and cold coagulation for cervical cancer screening in Nigeria.	Cancer	21/12/2024
136	An Idea Whose Time Has Come? An African Foresight Observatory on Genomics Medicine and Data-Intensive Global Science	Genetics and Genomics	21/12/2024
137	Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.	HIV/AIDS	21/12/2024
138	Demographic predictors of HIV serostatus among HIV counseling and testing clients in rural Nigeria.	HIV/AIDS	21/12/2024
139	Low Lymphocyte Count In HIV- Pregnancy And Strategies For Treatment. In Scientific Basis of Healthcare: AIDS & Pregnancy.	HIV/AIDS	21/12/2024
140	Confirmation of putative HIV-1 group P in Cameroon	HIV/AIDS	21/12/2024
141	High Frequency of HIV-1 Dual Infections in Cameroon, West Central Africa	HIV/AIDS	21/12/2024
142	The outcome of prevention of mother to child transmission (PMTCT) of HIV infection programme in Nnewi, southeast Nigeria.	MNCH	21/12/2024
143	Non-communicable diseases in sub-Saharan Africa: what we know now	NCDx	21/12/2024
144	Patient Retention and Adherence to Antiretrovirals in a Large Antiretroviral Therapy Program in Nigeria: A Longitudinal Analysis for Risk Factors.	HIV/AIDS	21/12/2024
145	Medical Ethics Education: A Survey of Opinion of Medical Students in a Nigerian University	Research capacity building	21/12/2024
146	Challenges in treating malignancies in HIV in Nigeria	Cancer	21/12/2024
147	Evaluation of the Detection Threshold of Three lmmunochromotographic Rapid Diagnostic Test (ROT) Kits for Falciparum Malaria Using Titration Technique	Malaria	21/12/2024

Generated by wpDataTables

PUBLICATIONS

Recent News

Social Network

Extra Links

Contact Us